Immediate Impact

50 standout
Sub-graph 1 of 21

Citing Papers

Biomaterials mediated 3R (remove-remodel-repair) strategy: holistic management of Helicobacter pylori infection
2025 Standout
ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis
2025 Standout
3 intermediate papers

Works of Yuichi Sakurai being referenced

Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study
2015
Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects
2015

Author Peers

Author Last Decade Papers Cites
Yuichi Sakurai 828 763 26 339 12 955
Yuuichi Sakurai 771 687 38 319 18 878
JP Idström 783 616 43 207 13 957
Hiroyuki Okamoto 658 590 44 286 29 848
Nigel Flook 731 621 13 169 26 934
G. D. Kerr 687 486 46 215 20 965
W. M. Wong 784 555 10 283 23 894
A A Wirz 931 577 87 253 18 1.1k
Kerstin Röhss 750 749 78 193 45 1.0k
Alain Farley 682 389 32 173 23 855
Pedro Almela 650 386 15 175 29 880

All Works

Loading papers...

Rankless by CCL
2026